SARAJEVO (Bosnia and Herzegovina), August 15 (SeeNews) – Bosnia’s biggest pharmaceutical company, blue-chip Bosnalijek, plans to raise its net profit in 2008 by 22% to 9.5 million marka ($7.2 million/4.9 million euro) on the back of higher sales and market expansion, a company official said on Friday.
